Catalyst Wire Dossier Catalyst Wire Dossier

Buprenorphine and naloxone sublingual film

Buprenorphine and naloxone · Alvogen Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Buprenorphine and naloxone sublingual film, covering 2019-01-24 to 2026-08-14. Get the full timeline:

Most recent: FDA Approved: BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM — Supplemental Application (Alvogen Inc.)

See pricing